Home/Filings/4/0001104659-24-127705
4//SEC Filing

Henderson Jane 4

Accession 0001104659-24-127705

CIK 0001974640other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 8:02 PM ET

Size

5.8 KB

Accession

0001104659-24-127705

Insider Transaction Report

Form 4
Period: 2024-12-09
Henderson Jane
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-09+124,962124,962 total
    Exercise: $49.07Exp: 2034-12-09Common Stock (124,962 underlying)
Footnotes (1)
  • [F1]This option represents the right to purchase 124,962 shares of the Issuer's common stock, and will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.

Issuer

Apogee Therapeutics, Inc.

CIK 0001974640

Entity typeother

Related Parties

1
  • filerCIK 0001422304

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:02 PM ET
Size
5.8 KB